$48.51
$0.00 (0.00%)
End-of-day quote: 06/01/2024
NasdaqGS:CYTK

Cytokinetics Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$7.53M $94.59M $70.43M $55.83M $26.87M $31.50M $13.37M $106.41M $28.66M $46.94M $30.65M $7.56M $4.00M $2.58M $81.54M $12.42M $13.62M $3.13M $8.91M $13.44M
GM % Gross Margin %
100.00% -154.59% -127.09% -73.66% -220.55% -182.96% 0.00% 39.48% -61.90% 5.36% -61.35% 0.00% 0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
OM Operating Margin
0.00% 0.00% -264.54% -168.27% 0.00% -282.26% 0.00% 13.33% -130.53% -31.43% -110.59% 0.00% 0.00% 0.00% 31.98% 0.00% 0.00% 0.00% 0.00% -285.92%
EPS Earnings Per Share
$0.00 $-5.45 $-4.05 $-2.80 $-1.97 $-2.11 $-1.95 $-2.59 $0.39 $-0.97 $-0.41 $-1.24 $-2.22 $-4.20 $-4.62 $2.52 $-6.54 $-6.18 $-9.36 $-8.88 $-11.28
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
-0.00% -0.00% 0 -0.00% 0 0 0 0 0 0 0 0 0 0 0 0 -0.00% -0.00% -0.00% 0
Sha. Shares
101.64m 94.83m 84.8m 71.02m 59.17m 54.72m 53.96m 40.65m 39.58m 38.66m 30.68m 23.74m 12.49m 11.15m 10.18m 8.26m 8.21m 7.21m 4.95m 4.74m
OCF Operating Cash Flow
$-414.33M $-299.52M $-142.52M $8.94M $-90.91M $-101.22M $-101.76M $36.98M $4.88M $-44.84M $-7.72M $-33.44M $-45.60M $-44.83M $8.42M $-61.33M $-3.01M $-47.17M $-39.48M $-34.03M
FCF Free Cash Flow
$-447.80M $-310.85M $-191.39M $-2.11M $-93.53M $-102.11M $-104.64M $35.39M $4.32M $-45.94M $-8.26M $-33.57M $-46.04M $-45.32M $7.87M $-61.99M $-5.57M $-52.54M $-40.95M $-35.43M
FCFS Free Cash Flow Per Share
$-4.31 $-3.46 $-2.49 $-0.03 $-1.62 $-1.88 $-2.12 $0.89 $0.11 $-1.29 $-0.30 $-1.85 $-3.90 $-4.24 $0.82 $-7.53 $-0.70 $-8.61 $-8.60 $-10.75